Joint Warwick study wins RCGP's Research Paper of the Year

October 22, 2015

Researchers from the University of Warwick have won a prestigious award for their work on diabetes.

The paper, entitled Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study, was named Research Paper of the Year in the diabetes category, by the Royal College of General Practitioners (RCGP). The RCGP award recognises an individual or group of researchers who have undertaken and published an exceptional piece of research relating to general practice or primary care.

The study was a collaboration with researchers from Gloucestershire Hospitals NHS Foundation Trust. The research was jointly led by Prof. Peter Scanlon (GHNHSFT) and Prof. Jackie Sturt (Kings College, London, formerly University of Warwick) and supported by Irene Stratton (senior statistician, Gloucestershire) and Dr Antje Lindemeyer (University of Birmingham, formerly University of Warwick).

The team from Warwick included Dr Alison Hipwell (CLAHRC WM at Warwick Business School, formerly of the medical school) who was responsible for the day to day running of the study and led the data-collection, and Warwick Medical School's Dr Roger Gadsby, Dr Paul O'Hare and Nidal al-Athamneh. Dr Hipwell said: "It is a great honour to have our work recognised by the RCGP this year. It has been a great experience to work with such a talented team of researchers from the University of Warwick and Gloucestershire Hospitals NHS Foundation Trust. Diabetic retinopathy is a serious complication of type one and type two diabetes and our research paper highlights the importance of multidisciplinary clinical practice in primary care."

The research looked into why uptake of eye screening can vary from 55 per cent to 95 per cent between practices. The paper looked at the factors contributing to high or low patient uptake of retinopathy screening in both urban and rural settings, including deprived and affluent areas. It found a number of issues including service and staff interaction and perceptions of non-attenders. The paper recommended a range of service-level opportunities to improve screening attendance and more research.
-end-
The research study was supported by a grant from the National Institute for Health Research (NIHR) Research for Patient Benefit programme and was conducted in Gloucestershire, Warwickshire and Birmingham.

The NHS Diabetic Eye Screening Programme aims to reduce the risk of sight loss among people with diabetes in England by allowing quick diagnosis and treatment of sight-threatening retinopathy. Diabetic retinopathy is a caused by diabetes when high blood sugar levels damage the tiny blood vessels in the back of the eye. Everyone with diabetes who is 12 years old or over is invited for screening once a year.

The paper was published in the British Journal of General Practice and can be read here: http://bjgp.org/content/64/625/e484

For further details please contact Nicola Jones, Communications Manager, University of Warwick 07824 540863 or N.Jones.1@warwick.ac.uk

Notes to Editors:

1. Category 6: Endocrinology (inc Diabetes), Gastroenterology, Musculoskeletal & Trauma, and Dermatology

2. Submissions were published between Jan. 1 and Dec. 31 2014. For more information about the award, please visit RCGP's website http://www.rcgp.org.uk/rpy

3. For more information about diabetic retinopathy, see: http://www.nhs.uk/conditions/diabetic-retinopathy/Pages/Introduction.aspx

University of Warwick

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.